首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   41744篇
  免费   4088篇
  国内免费   2480篇
耳鼻咽喉   355篇
儿科学   673篇
妇产科学   386篇
基础医学   4318篇
口腔科学   743篇
临床医学   5145篇
内科学   5359篇
皮肤病学   563篇
神经病学   1722篇
特种医学   1741篇
外国民族医学   7篇
外科学   3646篇
综合类   8291篇
现状与发展   12篇
一般理论   2篇
预防医学   3812篇
眼科学   714篇
药学   4888篇
  43篇
中国医学   3176篇
肿瘤学   2716篇
  2024年   129篇
  2023年   497篇
  2022年   1296篇
  2021年   1902篇
  2020年   1469篇
  2019年   1177篇
  2018年   1237篇
  2017年   1312篇
  2016年   1252篇
  2015年   1946篇
  2014年   2379篇
  2013年   2711篇
  2012年   3748篇
  2011年   4024篇
  2010年   2988篇
  2009年   2426篇
  2008年   2788篇
  2007年   2713篇
  2006年   2397篇
  2005年   2053篇
  2004年   1595篇
  2003年   1513篇
  2002年   1292篇
  2001年   968篇
  2000年   724篇
  1999年   439篇
  1998年   245篇
  1997年   212篇
  1996年   156篇
  1995年   139篇
  1994年   121篇
  1993年   73篇
  1992年   85篇
  1991年   68篇
  1990年   45篇
  1989年   39篇
  1988年   26篇
  1987年   21篇
  1986年   17篇
  1985年   11篇
  1984年   8篇
  1983年   7篇
  1981年   4篇
  1979年   21篇
  1978年   3篇
  1977年   3篇
  1976年   4篇
  1970年   4篇
  1969年   6篇
  1968年   3篇
排序方式: 共有10000条查询结果,搜索用时 93 毫秒
1.
目的:建立黑参中人参皂苷Rg_3的含量测定方法。方法:利用高效液相色谱法,采用Thermo色谱柱(250 mm×4.6 mm,5μm),以乙腈-水为流动相梯度洗脱,测定黑参中人参皂苷Rg_3含量。结果:研究表明,不同批次黑参中人参皂苷Rg_3的含量差别明显,平均含量为1.236 5 mg·g~(-1),最低含量为0.368 7 mg·g~(-1),最高含量为2.500 7 mg·g~(-1),相差6.8倍。结论:建立了黑参中人参皂苷Rg_3含量的测定方法,对不同批次样品进行测定后发现,人参皂苷Rg_3含量差别明显,为黑参的质量控制和开发利用提供参考。  相似文献   
2.
Direct peroral cholangioscopy (POC) using an ultra‐slim upper endoscope is one modality of POC for intraductal endoscopic evaluation and treatment of the bile duct. Choledochoduodenostomy (CDS) is one modality of biliary bypass surgery that provides a new route to the bile duct. We carried out direct POC using an ultra‐slim upper endoscope without the use of accessories in 10 patients (four sump syndromes, three bile duct strictures and three intrahepatic duct stones) previously undergoing surgical CDS. Direct POC was successful in all patients. The use of an intraductal balloon catheter was required in one patient for advancement of the endoscope into the bile duct. Distal bile ducts with sump syndromes were cleared using baskets and water irrigation under direct POC. Cholangiocarcinoma was diagnosed in one patient with hilar bile duct stricture after cholangioscopic evaluation and a targeting forceps biopsy under direct POC. Intrahepatic duct stones were successfully extracted after intraductal fragmentation under direct POC. Oozing bleeding occurred during intraductal lithotripsy but stopped spontaneously. Direct POC using an ultra‐slim upper endoscope without the assistance of accessories can easily be carried out in patients undergoing CDS.  相似文献   
3.
Since the new round of health care reform in 2009, the vertical integration of hospitals and primary health institutions has become widely implemented in China as an efficient method for improving quality of primary care. This study aimed to answer the following questions: (a) What is the perceived quality of township health centres (THCs) under integration? (B) What differences could be observed among the three typical integration models, namely, private hospital-THC integration, public hospital-THC integration, and loose collaboration? Two rounds of cross-sectional surveys were conducted from November 2016 to June 2018. The Chinese version of the Primary Care Assessment Tool was used to evaluate perceived quality of sample THCs, and 1118 adult patients were interviewed in total. Multiple linear regressions were employed to compare the quality scores between two survey rounds and among different integration models after controlling for potential confounders. The results revealed that the quality of care significantly improved under private hospital-THC integration as observed by comparing two survey rounds, while no change or slight changes were observed in the other two models. The difference observed among the three models was that the perceived quality of THCs integrated with private hospitals was worse than that of THCs integrated with public hospitals and THCs under loose collaboration, while no significant difference was observed between public hospital-THC integration and loose collaboration. Increased attention should be given to highlighting the tight integration between hospitals and THCs and the different roles played by private and public hospitals in the current reform.  相似文献   
4.
ABSTRACT

Purpose

Work-related eye injuries have been reported with a variety of epidemiologic and clinical characteristics. We aimed to identify epidemiologic characteristics of work-related eye injuries and risk factors associated with severe injury in a large metropolitan city.  相似文献   
5.
Abstract

Objective

The sex, age, medical history, treatment, tobacco use, race risk (SAMe-TT2R2) Score; the sex, age, medical history, treatment, tobacco use, genotype combination (SAMe-TT2G2) Score; and the so-called modified SAMe-TT2R2 scores have been proposed to predict the anticoagulation quality for patients with non-valvular atrial fibrillation (NVAF). The data from a prospective controlled study is used to validate the SAMe-TT2R2 and SAMe-TT2G2 scores in Chinese NVAF patients treated with warfarin and to evaluate the association of factors with time in therapeutic range (TTR) to predict the quality of oral anticoagulation control.  相似文献   
6.
目的 分析青岛市2018年1例输入性恶性疟的死亡原因,为预防疟疾死亡病例发生提供参考。方法 访谈接诊医生及患者家属,对患者病历和流行病学调查资料进行分析。结果 患者刘某,男,35岁,青岛市城阳区人,2018年3月19日到科特迪瓦务工,7月17日回国。25日患者到韩国办事,26日下午出现发冷、发热、出汗、头痛、浑身酸痛等症状,26—27日自服退烧药无好转,28日上午到韩国某医院就诊,未明确诊断,下午出现腹泻、呕吐症状,29日下午回国,14∶59到城阳区人民医院就诊,精神萎靡,经询问患者有非洲出国史可能患疟疾,16∶30将患者转诊至疟疾治疗定点医院,17∶50到达青岛市传染病医院时患者呈深昏迷状态,医生考虑患者病情危重且该院正在改建无ICU病房,建议转至有抢救条件的综合医院抢救。19:40患者转入海慈医疗集团ICU病房,21∶00被确诊为恶性疟,因病情危重,患者于30日14∶15死于多脏器功能衰竭。结论 对于输入性疟疾,根据流行病学史、临床症状和实验室检测结果尽早明确诊断,尽早使用抗疟药治疗,是避免出现死亡病例的关键。  相似文献   
7.
8.
The acquisition of chemoresistance remains a major cause of cancer mortality due to the limited accessibility of targeted or immune therapies. However, given that severe alterations of molecular features during epithelial‐to‐mesenchymal transition (EMT) lead to acquired chemoresistance, emerging studies have focused on identifying targetable drivers associated with acquired chemoresistance. Particularly, AXL, a key receptor tyrosine kinase that confers resistance against targets and chemotherapeutics, is highly expressed in mesenchymal cancer cells. However, the underlying mechanism of AXL induction in mesenchymal cancer cells is poorly understood. Our study revealed that the YAP signature, which was highly enriched in mesenchymal‐type lung cancer, was closely correlated to AXL expression in 181 lung cancer cell lines. Moreover, using isogenic lung cancer cell pairs, we also found that doxorubicin treatment induced YAP nuclear translocation in mesenchymal‐type lung cancer cells to induce AXL expression. Additionally, the concurrent activation of TGFβ signaling coordinated YAP‐dependent AXL expression through SMAD4. These data suggest that crosstalk between YAP and the TGFβ/SMAD axis upon treatment with chemotherapeutics might be a promising target to improve chemosensitivity in mesenchymal‐type lung cancer.

Abbreviations

AUC
area under the curve
AXL
AXL receptor tyrosine kinase
BCL2
B‐cell lymphoma 2
CTD2
cancer target discovery and development
CTGF
connective tissue growth factor
DEG
differentially expressed genes
DOXO
doxorubicin
EMT
epithelial–mesenchymal transition
Eto
etoposide
FDA
Food and Drug Administration
ITGB3
integrin beta‐3
MAPK
mitogen‐activated protein kinase
MMP2
matrix metalloproteinase‐2
MMP9
matrix metalloproteinase‐9
mRNA
messenger RNA
NF‐κB
nuclear factor kappa‐light‐chain‐enhancer of activated B cells
SBE
SMAD binding element
SERPINE1
serpin family E member 1
siRNA
small interfering RNA
ssGSEA
single‐sample gene set enrichment analysis
TCGA
The Cancer Genome Atlas
TGFβ
transforming growth factor beta
YAP
Yes‐associated protein
YAP8SA
mutants of inhibitory phosphorylation site at eight serine to Alanine of YAP
ZEB1
zinc finger E‐box binding homeobox 1
ZEB2
zinc finger E‐box‐binding homeobox 2
  相似文献   
9.
10.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号